Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma—a review and prospects for the future
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F23%3A00078352" target="_blank" >RIV/65269705:_____/23:00078352 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/23:00131614
Result on the web
<a href="https://www.frontiersin.org/articles/10.3389/fcvm.2023.1243531/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fcvm.2023.1243531/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fcvm.2023.1243531" target="_blank" >10.3389/fcvm.2023.1243531</a>
Alternative languages
Result language
angličtina
Original language name
Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma—a review and prospects for the future
Original language description
Treatment of malignant lymphoma has for years been represented by many cardiotoxic agents especially anthracyclines, cyclophosphamide, and thoracic irradiation. Although they are in clinical practice for decades, the precise mechanism of cardiotoxicity and effective prevention is still part of the research. At this article we discuss most routinely used anti-cancer drugs in chemotherapeutic regiments for malignant lymphoma with the focus on novel insight on molecular mechanisms of cardiotoxicity. Understanding toxicity at molecular levels may unveil possible targets of cardioprotective supportive therapy or optimization of current therapeutic protocols. Additionally, we review novel specific targeted therapy and its challenges in cardio-oncology.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Frontiers in Cardiovascular Medicine
ISSN
2297-055X
e-ISSN
2297-055X
Volume of the periodical
10
Issue of the periodical within the volume
2023
Country of publishing house
CH - SWITZERLAND
Number of pages
16
Pages from-to
1243531
UT code for WoS article
001064769300001
EID of the result in the Scopus database
2-s2.0-85170709984